Copy of Newspaper Publication

Date: 5th August, 2026 To, To, The Manager, The Manager, Department of Corporate Services, Listing Department, BSE Limited National Stock Exchange of India Ltd. P. J. Towers, Dalal Street, 'Exchange Plaza', Bandra Kurla Complex, Fort, Mumbai - 400 001 Bandra (E), Mumbai - 400 051 Scrip Code: 533573 NSE Symbol: APLL TD Dear Sir/Madam, Sub: Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 - Publication of Unaudited Financial Results. With reference to the captioned subject, we enclose herewith Newspaper cuttings of extract of Unaudited Financial Results for the quarter ended 30th June, 2026, published in Economic Times & Indian Express (English Edition) and Financial Express (Gujarati Edition) on 5th August, 2026. We request you to kindly take the same on record. Thanking you, Yours faithfully, For Alembic Pharmaceuticals Limited ~aSaraf Company Secretary Encl.: A/a. ALEMBIC PHARMACEUTICALS LIMITED REGD. OFFICE: ALEMBIC ROAD, VADODARA- 390 003. •TEL: (0265) 2280550, 2280880 Website: www.alembicpharmaceuticals.com •E-mail: alembic@alembic.co.in • CIN: L24230GJ2010PLC061123 THE ECONOMIC TIMES I AHMEDABAID I WEDNESDAY I 5 AUGUST 2026 I WWW.ECONOMICTIMES.COM Alembic~ ALEMBIC 'pHARMACEUTICALS LIMITED' CIN: L24230G 201 OPLC061123 -- Touching Lives over · Regd.Office: Alembic Road, Vadodara - 390 003 Tel.: ([)265 6631000 E-mail: apl.investors@alembic.co.in Website: www.r11embicpharmaceuticals.com Extract of statement of Consolidated Unaudited Financial Results for the quarter ende'!, 3Q~h June, 2026 (~ in Crores except per share data) Ir' ., Quarter Ended Year Ended Particulars JI 30~06.2026 30.06.2025 31.03.2026 (U~audited) (Unaudited) (Audited) Total Income from Operations II 2,149.77 1,710.72 7,344.90' Net Profit for the period (before Tax, Exceptional 221.86 190.10 760.94 and/ or Extraordinary items) Net Profit for the period before tax (after II 221.86 190.10 693.95 Exceptional and/ or Extraordinary items) Net Profit for the period after tax attributable to shareholders of the company (after Exceptional 173.07 154.38 674.77 and/ or Extraordinary items) Total Comprehens!ve Income for the period .. 11174.63 154.33 695.69 Equity Share Capitar 1r 39.31 3~.31 39.31· I · Reserves (excluding Hevaluatlon Reserve) as shown in the Audited Balance Sheet of - - 5,635.50 previous year 11' Earning Per Share (Face Value of ~2/- each) 8.80 7.85 34.33 Basic & Diluted Notes: 11 " Ii Quarter Ended Year Ended 1. Standalone details 30.06.2026 30.06.2025 31.03.2026 (Un,, audited) (Unaudited) (Audited) Total Income from Operations 1,868.06 1,494.17 6,651.38 · Profit Before Exceptional Item and Tax "255.90 125.52 . 721.10 Profit After Tax 196.96 103.52 640.42 2. The above is an extract of the detailed format f the unaudited financial results filed with the Stock Exchanges. The detailed Financial Results are available on the Stock Exchange's website at www.nseindia.com and www.bseindia.com and Company's website (URL: https://alembicpharmaceuticals.com/ql!Jarterly-results). The same can also be accessed by scanning the Quick Response (QR) Code provided below. r. . ~.:;~ ~ti:. ':f J :; - ·. -;:, I I: ...~.~.. y: ~.~ . , .. rB a:i :l . .~ . ,:rr,'11 :: . [~!i:j:,• .~-..-· ~-.· . ~:, .:... ~~ ~~ FII o r Alembic Pharmaceuticals Limited . 111.~~. ;r~r.i11;r~ F ::. i' Sd/- . ~. Place Mumbai Chirayu Amin Date . 41 h August, 2026 ' II Chairman ...... •' :,' -·· WEDNESDAY.AUGUST 5,2026 THE INDIAN EXPRESS Alembic~ ALEMBIC PHARMACEUTICALS LIMITED _......,.,__."Jg)~ CIN: L24230GJ2010PLC061123 . · Regd.Office: Alembic Road, Vadodara • 390 003 Tel.: 0265 6637000 E-mail: apl.investors@alembic.co.in Website: www.alemb'cpharmaceuticals.com Extract of statement of Consolidated Unaudited Financial Results for the quarter ended 30th June, 2026 ~ In Crores except per share data) Quarter Ended Year Ended Particulars 30.06.2026 30.06.2025 31.03.2026 (Unaudited) (Unaudited) (Audited) Total Income from Operations 2,149.77 1,710.72 7,344.90 Net Profit for the pertod (before Tax, Exceptional and/ or Extraordinary Items) ,221.86 190.10 760.94 Net Profit for the pertod before tax (alter 221.86 190.10 693.95 Excepponal and/ or Extraordinary Items) Net Profit for the pertod alter tax attrtbutable to shareholders of the company (alter Exceptional 173.07 154.38 674.77 and/ or Extraordinary Items) Total Comprehensive Income for the pertod 174.63 154.33 695.69 Equity Share Capita! 39.31 39.31 39.31 Reserves (excluding Revaluation Reserve) as shown in the Audited Balance Sheet of 5,635.50 previous year Earning Per Share (Face Value of W· each) 8.80 7.85 34.33 Basic & Diluted Notes: Quarter Ended Year Ended 1. Standalone details 30.06.2026 30.06.2025 31.03.2026 (Unaudited) (Unaudited) (Audited) Total Income from Operations 1,868.06 1,494.17 6,651.38 Profit Before Exceptional. Item and Tax 255.90 125.52 721.10 Profit Alter Tax 196.96 103.52 640.42 2. The above is an extract of the detailed format of the unaudited financial results filed with the Stock Exchanges. The detailed Rnancial Results are available on the Stock Exchange•s website at www.nseindia.com and www.bseindia.com and Company's website (URL: https://alembicpharmaceuticals.com/quarter1y-results). The same can also be accessed by scanning the Quick Response (QR) Code provided below. For Alembic Pharmaceuticals Limited Sd/· Chlrayu Amin • Chairman Alembic).. ALEMBIC PHARMACEUTICALS LIMITED __ ,__."JQ?~ CIN: L24230GJ201~PLC061123 Regd.Olfice: Ale[11b1c Road, Vadodara - 390 003 Tel.: 0265 6637000 E-mail: apl.investors@alembic.co.in Website: www.al mbicpharmaceuticals.com Extract of statement of Consolidated Unaudited Financial Results for the quarter ended 30111 June, 2026 ~ in Crores except per share.data) Quarter Ended Year Ended Particulars 30.06.2026 30.06.2025 31.03.2026 (Unaudited) (Unaudited) (Audited} Total income from Operations 2,149.77 1,710.72 7,344.90 Net Profit for the period (before Tax, Exceptional and/ or Extraordinary items) 190.10 760.94 Net Profit for the penod before tax (after Exceptional and/ or Extraordinary items) 190.10 693.95 Net Profit for the period after tax attributable to shareholders of the company (after Exceptional 154.38 674.77 and/ or Extraordinary items) Total Comprehensive Income for the period 174.63 154.33 695.69 Equity Share Capital 39.31 39.31 39.31 Reserves (excluding Revaluation Reserve) as shown in the Audited Balance Sheet of 5,635.50 previous year Earning Per Share (Face Value of W- each) Basic & Diluted 8.80 7.85 34.33 Notes: Quarter Ended Year Ended 1. Standalone details 30.06.2026 30.06.2025 31.03.2026 (Unaudited) (Unaudited) (Audited) Total Income from Operations 1,868.06 1,494.17 6,651.38 Profit Before Exceptional Item and Tax 255.90 125.52 721.10 Profit After Tax 196.96 103.52 640.42 2. The above is an extract of the detailed format of the unaudited financial results filed with the Stock Exchanges. The detailed Financial Results are available on the Stock Exchange•s website at www.nseindia.com and www.bselndia.com and Company's website (URL: https://alembicpharmaceuticals.corntquarterty-restl1ts). The same can also be accessed y scanning the Quickl!esponse (QR) Co~w. For Alembic Pharmaceuticals Umited Place : Mumbai Chlrayu Amin Date : 4• August, 2026 Chairman